Document Detail

Positive outcome after intentional overdose of dabigatran.
MedLine Citation:
PMID:  23212788     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Dabigatran (Pradaxa™), an orally active direct thrombin inhibitor, was approved by the United States Food and Drug Administration for the prevention of stroke in patients with atrial fibrillation in October 2010. Life-threatening consequences from dabigatran therapy include hemorrhage and bleeding complications, but they typically occur after renal impairment. We describe the first case report of intentional, acute overdose with dabigatran.
CASE REPORT: A 57-year-old woman with a medical history of depression and atrial fibrillation presented to the emergency department after ingesting 11.25 g of dabigatran in a suicide attempt. Despite an ecchymosis indicative of prior trauma, there was no evidence of acute bleeding. After receiving gastric lavage and activated charcoal therapy in the emergency department, she was admitted to the ICU. On presentation, dabigatran blood levels measured 970 ng/mL and thrombin clot times measured above the testable limits (>120 s) until 52 h post-arrival. The remainder of her clinical course was uncomplicated, and the patient was transferred to an inpatient psychiatric unit for depression follow-up.
DISCUSSION: This case shows the clinical course of a patient with an acute, massive dabigatran overdose with no significant clinical consequences. Currently, there is no ideal method to monitor anticoagulation levels; there is no pharmacologic reversal method, and hemodialysis is an undesirable treatment option.
Jason S Woo; Neel Kapadia; Sarah E Phanco; Catherine A Lynch
Related Documents :
20951658 - The outcome of reduction mammaplasty remains stable at 2-5 years' follow-up: a prospect...
9258818 - Effect of neurological dysfunction on health-related quality of life in patients with h...
25399408 - Virtual reality using games for improving physical functioning in older adults: a syste...
16143178 - Unilateral profound hearing loss and the effect on quality of life after cerebelloponti...
24025918 - Rhtsh-aided low-activity versus high-activity regimens of radioiodine in residual ablat...
10426648 - A prospective placebo controlled double blind randomised study to investigate the use o...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of medical toxicology : official journal of the American College of Medical Toxicology     Volume:  9     ISSN:  1937-6995     ISO Abbreviation:  J Med Toxicol     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-05-20     Completed Date:  2013-12-17     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  101284598     Medline TA:  J Med Toxicol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  192-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithrombins / blood,  pharmacokinetics,  poisoning*
Benzimidazoles / blood,  pharmacokinetics,  poisoning*
Charcoal / therapeutic use
Chelating Agents / therapeutic use
Drug Overdose / blood,  therapy*
Emergency Service, Hospital
Gastric Lavage
Middle Aged
Suicide, Attempted
Treatment Outcome
beta-Alanine / analogs & derivatives*,  blood,  pharmacokinetics,  poisoning
Reg. No./Substance:
0/Antithrombins; 0/Benzimidazoles; 0/Chelating Agents; 11P2JDE17B/beta-Alanine; 16291-96-6/Charcoal; I0VM4M70GC/dabigatran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fast Screening of Authentic Ginseng Products by Surface Desorption Atmospheric Pressure Chemical Ion...
Next Document:  Preoperative Magnetic Resonance Angiography as a Predictive Test for Cerebral Ischemia During Caroti...